20/20 Biolabs, Inc. (AIDX) earnings
Quarterly results of 20/20 Biolabs, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 4 quarters, the latest results release and when the next one is expected.
Next earnings date
20/20 Biolabs, Inc. was expected to report around October 26, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) 20/20 Biolabs, Inc. reported revenue of $730.6K (+36.5% on the same quarter a year earlier) and a net loss of $1.5M.
Diluted earnings per share were -$0.26.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $730.6K | +36.5% | -$1.5M | -$0.26 |
| Q1 FY2026 | $353.4K | -36.2% | -$2.2M | -$0.28 |
| Q2 FY2025 | $535.1K | - | -$840.9K | -$0.17 |
| Q1 FY2025 | $553.8K | - | -$764.6K | -$0.16 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly results 8-K
When is 20/20 Biolabs, Inc.'s next earnings date?
20/20 Biolabs, Inc. was expected to report around October 26, 2026; nothing is on file with the SEC yet.
What were 20/20 Biolabs, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, 20/20 Biolabs, Inc. reported revenue of $730.6K and a net loss of $1.5M. The figures come from its filing with the SEC.
Is 20/20 Biolabs, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $730.6K, up 36.5% from $535.1K in the same quarter a year earlier.
Get an email when AIDX reports
Follow AIDX and we email you its next results the day they are filed, with the numbers explained.